文献速递神经肿瘤小儿神经外科与脑积水

美国中枢神经系统肿瘤亚型导致的寿命损失年

Years of life lost due to central nervous system tumor subtypes in the United States.
PubMed 文献 · Neuro Oncol · 2025-01-01

本研究基于2018年美国死亡与发病数据,按肿瘤组织病理类型估算中枢神经系统肿瘤的寿命损失年(YLL)。恶性中枢神经系统肿瘤总YLL为364 223年(平均YLL=21.2年),非恶性为15 472年(平均YLL=14.2年);胶质母细胞瘤占恶性总YLL的58.8%,儿童髓母细胞瘤平均YLL最高(61.2年)。

要点

  • 恶性中枢神经系统肿瘤总YLL远高于非恶性,胶质母细胞瘤贡献最大。
  • 儿童恶性中枢神经系统肿瘤平均YLL最高,髓母细胞瘤达61.2年。
  • YLL量化或有助于合理分配临床与研究资源。

核心结论

  • 恶性中枢神经系统肿瘤尤其是胶质母细胞瘤对总YLL贡献最大,而儿童中枢神经系统恶性肿瘤平均YLL最高。

研究设计与样本

  • 基于2018年美国国家生命统计系统和国家癌症登记计划的死亡率、发病率和预期寿命数据,按肿瘤组织病理类型估算YLL和平均YLL。

主要发现

  • 2018年恶性中枢神经系统肿瘤总YLL为364 223年(平均YLL=21.2年),非恶性为15 472年(平均YLL=14.2年)。
  • 胶质母细胞瘤占所有原发性中枢神经系统肿瘤YLL的58.8%,平均YLL=19.8年。
  • 非恶性脑膜瘤占所有原发性中枢神经系统肿瘤YLL的2.9%,平均YLL=14.4年。
  • 儿童髓母细胞瘤平均YLL为61.2年,其他胚胎性肿瘤平均YLL为50.7年。

临床怎么用

  • YLL量化可与其他流行病学数据结合,帮助合理分配临床和研究资源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Years of life lost (YLL) is a disease burden measure quantifying the number of years lost due to premature mortality for a given disease. The present study sought to assess YLL for primary brain and other central nervous system (CNS) tumor histopathologies in the United States. METHODS: Mortality, incidence, and life expectancy data for mortalities occurring in 2018 were obtained from the National Vital Statistics System and the National Program of Cancer Registries. Tumor-specific YLL were estimated by subtracting age of death from projected life expectancy; mean YLL (mYLL) was determined to assess the impact of CNS tumor diagnosis on the individual patient level. RESULTS: For mortalities occurring in 2018, the total YLL due to malignant CNS tumors was 364 223 years (mYLL = 21.2 years), compared to 15 472 years (mYLL = 14.2 years) for nonmalignant tumors. Glioblastoma had the highest total YLL among malignant CNS tumors (58.8% of all primary CNS tumor YLL; mYLL = 19.8 years), and nonmalignant meningioma among nonmalignant CNS tumors (2.9% of all primary CNS tumor YLL; mYLL = 14.4 years). Malignant pediatric tumors had the greatest mYLL, with medulloblastoma having a mYLL of 61.2 years and other embryonal tumors having an mYLL of 50.7. CONCLUSIONS: Malignant CNS tumors, glioblastoma in particular, contributed the most to total YLL, whereas pediatric CNS malignancies had the greatest mYLL. Used with other epidemiological data, the authors contend that this quantification may help rationalize the allocation of clinical and research resources.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Gerstl JVE, Price M, Bernstock JD, et al. Years of life lost due to central nervous system tumor subtypes in the United States. Neuro Oncol. 2025. PMID: 40517297. doi:10.1093/neuonc/noaf142

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。